Sentry Investment Management LLC Gilead Sciences, Inc. Transaction History

Sentry Investment Management LLC

$238 Million
Q3 2024

A detailed history of Sentry Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sentry Investment Management LLC holds 6,048 shares of GILD stock, worth $558,895. This represents 0.21% of its overall portfolio holdings.

Number of Shares

6,048

Previous 6,048 -0.0%

Holding current value

$558,895

Previous $415,000 22.17%

% of portfolio

0.21%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$63.15 - $72.88 $78,242 - $90,298	-1,239 Reduced 17.0%	6,048 $415,000
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $53,971 - $65,816	754 Added 11.54%	7,287 $534,000
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $51,435 - $58,329	-702 Reduced 9.7%	6,533 $529,000
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $115,346 - $125,845	-1,560 Reduced 17.74%	7,235 $542,000
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $39,449 - $44,997	519 Added 6.27%	8,795 $678,000
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $28,527 - $32,501	-369 Reduced 4.27%	8,276 $687,000
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $17,511 - $25,141	281 Added 3.36%	8,645 $742,000
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $94,025 - $105,901	-1,629 Reduced 16.3%	8,364 $517,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $139,992 - $175,425	-2,417 Reduced 19.48%	9,993 $594,000
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $122,721 - $132,403	-1,813 Reduced 12.75%	12,410 $867,000
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $757,641 - $827,830	-11,937 Reduced 45.63%	14,223 $979,000
Q1 2021 Apr 21, 2021	SELL	$60.0 - $68.46 $2.65 Million - $3.02 Million	-44,150 Reduced 62.79%	26,160 $1.69 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $3.18 Million - $3.63 Million	-56,210 Reduced 44.43%	70,310 $4.1 Million
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $1,366 - $1,717	-22 Reduced 0.02%	126,520 $8 Million
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $181,428 - $210,672	2,508 Added 2.02%	126,542 $9.74 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $2.81 Million - $3.6 Million	44,887 Added 56.71%	124,034 $9.27 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $3.08 Million - $3.45 Million	-49,225 Reduced 38.35%	79,147 $5.15 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $201,295 - $262,675	-3,325 Reduced 2.52%	128,372 $8.03 Million
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $453,697 - $502,325	6,365 Added 5.08%	131,697 $10.2 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $769,282 - $897,337	-11,857 Reduced 8.64%	125,332 $8.88 Million
Q1 2018 May 02, 2018	SELL	$72.84 - $88.8 $948,959 - $1.16 Million	-13,028 Reduced 8.67%	137,189 $10.3 Million
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $614,095 - $720,861	8,631 Added 6.1%	150,217 $10.8 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $107,155 - $127,008	1,486 Added 1.06%	141,586 $11.5 Million
Q2 2017 Aug 21, 2017	BUY	N/A	140,100	140,100 $9.92 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.

Account

Sentry Investment Management LLC Gilead Sciences, Inc. Transaction History